Position in RPRX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,661,236
+$654,665 QoQ
Shares Held
29,628
+13.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#282
of 641 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AE Wealth Management LLC holds $11,774,403 across 15 Biotechnology names. RPRX ranks #4 (14.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
24,046 | $2,725,848 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,871 | $1,922,817 | |
| 3 | EXEL |
Exelixis, Inc.
|
32,548 | $1,770,929 | |
| 4 | RPRX |
Royalty Pharma plc
This page
|
29,628 | $1,661,236 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
3,184 | $767,232 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,094 | $682,131 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
8,050 | $656,141 | |
| 8 | CYTK |
Cytokinetics Inc
|
5,316 | $452,857 |
All Filings in RPRX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,661,236 | 29,628 | Shares | Other | 2026-08-03 | |
| 2025-12-31 | $1,006,571 | 26,050 | Shares | Other | 2026-01-26 | |
| 2025-09-30 | $886,267 | 25,121 | Shares | Other | 2025-11-03 | |
| 2025-06-30 | $1,952,789 | 54,199 | Shares | Other | 2025-08-06 | |
| 2025-03-31 | $1,713,924 | 55,057 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,487,284 | 58,302 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,662,800 | 58,777 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $1,661,257 | 62,998 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||